How Context can Impact Clinical Trials : 31 A Multi-Country Qualitative Case Study Comparison of Diagnostic Biomarker Test 32 Interventions
暂无分享,去创建一个
[1] N. Day,et al. Retrospective review of the management of acute infections and the indications for antibiotic prescription in primary care in northern Thailand , 2018, BMJ Open.
[2] A. O’Cathain. A Practical Guide to Using Qualitative Research with Randomized Controlled Trials , 2018, Oxford Medicine Online.
[3] Marco J. Haenssgen,et al. A Comparison of Patients’ Local Conceptions of Illness and Medicines in the Context of C-Reactive Protein Biomarker Testing in Chiang Rai and Yangon , 2018, The American journal of tropical medicine and hygiene.
[4] Clotilde Rambaud-Althaus,et al. A novel electronic algorithm using host biomarker point-of-care tests for the management of febrile illnesses in Tanzanian children (e-POCT): A randomized, controlled non-inferiority trial , 2017, PLoS medicine.
[5] Deborah E. White,et al. Thematic Analysis , 2017 .
[6] Nithima Sumpradit. New chapter in tackling antimicrobial resistance in Thailand , 2017, British Medical Journal.
[7] C. Del Mar,et al. Delayed antibiotic prescriptions for respiratory infections. , 2017, The Cochrane database of systematic reviews.
[8] P. Póvoa,et al. Biomarker-guided antibiotic therapy-strengths and limitations. , 2017, Annals of translational medicine.
[9] A. Kotwani,et al. Antibiotic use in South East Asia and policies to promote appropriate use: reports from country situational analyses , 2017, British Medical Journal.
[10] W. Oo,et al. Poverty among households living in slum area of Hlaing Tharyar Township, Yangon City, Myanmar , 2017 .
[11] A. Sommanustweechai,et al. Antimicrobial resistance: from global agenda to national strategic plan, Thailand , 2017, Bulletin of the World Health Organization.
[12] Y. Lubell,et al. Biomarker tests for bacterial infection-a costly wait for the holy grail. , 2017, The Lancet. Infectious diseases.
[13] S. P. Kachur,et al. Impact of introduction of rapid diagnostic tests for malaria on antibiotic prescribing: analysis of observational and randomised studies in public and private healthcare settings , 2017, British Medical Journal.
[14] S. Michie,et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. , 2017, The Cochrane database of systematic reviews.
[15] C. Stålsby Lundborg,et al. Antibiotic prescribing and dispensing for acute respiratory infections in children: effectiveness of a multi-faceted intervention for health-care providers in Vietnam , 2017, Global health action.
[16] G. Mtove,et al. Point‐of‐care assessment of C‐reactive protein and white blood cell count to identify bacterial aetiologies in malaria‐negative paediatric fevers in Tanzania , 2016, Tropical medicine & international health : TM & IH.
[17] D. Skinner,et al. It’s complicated: why do tuberculosis patients not initiate or stay adherent to treatment? A qualitative study from South Africa , 2016, BMC Infectious Diseases.
[18] H. Wertheim,et al. Point-of-care C-reactive protein testing to reduce inappropriate use of antibiotics for non-severe acute respiratory infections in Vietnamese primary health care: a randomised controlled trial , 2016, The Lancet. Global health.
[19] James Barlow,et al. Point-of-care C reactive protein for the diagnosis of lower respiratory tract infection in NHS primary care: a qualitative study of barriers and facilitators to adoption , 2016, BMJ Open.
[20] E. Hutchinson,et al. The complexities of simple technologies: re-imagining the role of rapid diagnostic tests in malaria control efforts , 2016, Malaria Journal.
[21] J. Donovan,et al. Maximising the impact of qualitative research in feasibility studies for randomised controlled trials: guidance for researchers , 2015, Trials.
[22] P. Newton,et al. Performance of C-reactive protein and procalcitonin to distinguish viral from bacterial and malarial causes of fever in Southeast Asia , 2015, BMC Infectious Diseases.
[23] P. Garner,et al. Directly observed therapy for treating tuberculosis , 2015, The Cochrane database of systematic reviews.
[24] Fabrice Quet,et al. Antibiotic prescription behaviours in Lao People's Democratic Republic: a knowledge, attitude and practice survey , 2015, Bulletin of the World Health Organization.
[25] V. Wiseman,et al. The practice of ‘doing’ evaluation: lessons learned from nine complex intervention trials in action , 2014, Implementation Science.
[26] Koen Peeters Grietens,et al. Success or failure of critical steps in community case management of malaria with rapid diagnostic tests: a systematic review , 2014, Malaria Journal.
[27] N. Engel,et al. Situating Standards in Practices: Multi Drug-Resistant Tuberculosis Treatment in India , 2014 .
[28] W. Bishai,et al. Diagnostic point-of-care tests in resource-limited settings. , 2014, The Lancet. Infectious diseases.
[29] P. Horby,et al. Antibiotic sales in rural and urban pharmacies in northern Vietnam: an observational study , 2014, BMC Pharmacology and Toxicology.
[30] P. Horby,et al. Antibiotic use and resistance in emerging economies: a situation analysis for Viet Nam , 2013, BMC Public Health.
[31] J. Porter,et al. Ethical aspects of directly observed treatment for tuberculosis: a cross-cultural comparison , 2013, BMC medical ethics.
[32] Sandy Oliver,et al. Using qualitative evidence on patients’ views to help understand variation in effectiveness of complex interventions: a qualitative comparative analysis , 2013, Trials.
[33] Pat Bazeley,et al. Qualitative Data Analysis: Practical Strategies , 2013 .
[34] P. Suwanwaree,et al. Antibiotics Smart Use: a workable model for promoting the rational use of medicines in Thailand. , 2012, Bulletin of the World Health Organization.
[35] S. Treweek,et al. Intervention description is not enough: evidence from an in-depth multiple case study on the untold role and impact of context in randomised controlled trials of seven complex interventions , 2012, Trials.
[36] L. Potvin,et al. Context by treatment interactions as the primary object of study in cluster randomized controlled trials of population health interventions , 2012, International Journal of Public Health.
[37] I. Okeke,et al. Non-prescription antimicrobial use worldwide: a systematic review. , 2011, The Lancet. Infectious diseases.
[38] P. Dupas. Health Behavior in Developing Countries , 2011 .
[39] N. Woodford,et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study , 2010, The Lancet. Infectious diseases.
[40] David M Kent,et al. Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal , 2010, Trials.
[41] D. Wild,et al. Assessing and demonstrating data saturation in qualitative inquiry supporting patient-reported outcomes research , 2010, Expert review of pharmacoeconomics & outcomes research.
[42] R. Pill,et al. Why do interventions work in some places and not others: a breastfeeding support group trial. , 2010, Social science & medicine.
[43] Geert-Jan Dinant,et al. Point-of-Care C-Reactive Protein Testing and Antibiotic Prescribing for Respiratory Tract Infections: A Randomized Controlled Trial , 2010, The Annals of Family Medicine.
[44] Claire Glenton,et al. Use of qualitative methods alongside randomised controlled trials of complex healthcare interventions: methodological study , 2009, BMJ : British Medical Journal.
[45] J. Lowery,et al. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science , 2009, Implementation science : IS.
[46] David M Kent,et al. Against pragmatism: on efficacy, effectiveness and the real world , 2009, Trials.
[47] H. Goossens,et al. Variation in antibiotic prescribing and its impact on recovery in patients with acute cough in primary care: prospective study in 13 countries , 2009, BMJ : British Medical Journal.
[48] I. Okeke,et al. Antimicrobial resistance in developing countries. Part II: strategies for containment. , 2005, The Lancet. Infectious diseases.
[49] Richard L Kravitz,et al. Evidence-based medicine, heterogeneity of treatment effects, and the trouble with averages. , 2004, The Milbank quarterly.
[50] Alan Shiell,et al. Methods for exploring implementation variation and local context within a cluster randomised community intervention trial , 2004, Journal of Epidemiology and Community Health.
[51] Aryanti Radyowijati,et al. Improving antibiotic use in low-income countries: an overview of evidence on determinants. , 2003, Social science & medicine.
[52] Jo Rycroft-Malone,et al. Nursing Theory and Concept Development or Analysis Getting Evidence into Practice: the Meaning of 'context' , 2022 .
[53] C. Thomas. Trade policy and the politics of access to drugs , 2002 .
[54] Christopher H Schmid,et al. Summing up evidence: one answer is not always enough , 1998, The Lancet.
[55] T. Apidechkul,et al. Inequity in Accessing Health Care Service in Thailand in 2015: A Case Study of the Hill Tribe People in Mae Fah Luang District, Chiang Rai, Thailand , 2016 .
[56] M. F. Jeffrey A. Linder MD. Comparative Effectiveness of Three Anxiolytics for Acute Respiratory Infections: Antibiotics, C-Reactive Protein Point-of-Care Testing, and Improved Communication , 2015, Journal of General Internal Medicine.
[57] Ngoc Quang Minh Ngo,et al. Outpatient antibiotic use in acute respiratory infections in Ho Chi Minh City, Vietnam , 2014 .
[58] G. Guest,et al. How Many Interviews Are Enough? An Experiment with Data Saturation and Variability , 2005 .
[59] P. Kraipornsak,et al. Impact of the World Trade Organization TRIPS agreement on the pharmaceutical industry in Thailand. , 2001, Bulletin of the World Health Organization.
[60] H. Federrath,et al. Design issues , 2008 .
[61] B. Berg. Qualitative Research Methods for the Social Sciences , 1989 .